106 related articles for article (PubMed ID: 12586202)
1. Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A.
Ma X; Wang H; Xin J; Zhang T; Tu Z
Eur J Pharmacol; 2003 Feb; 461(2-3):89-92. PubMed ID: 12586202
[TBL] [Abstract][Full Text] [Related]
2. Effects of huperzine A on liver cytochrome P-450 in rats.
Ma XC; Wang HX; Xin J; Zhang T; Tu ZH
Acta Pharmacol Sin; 2003 Aug; 24(8):831-5. PubMed ID: 12904285
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
[TBL] [Abstract][Full Text] [Related]
4. Investigation of cytochrome P450 1A2 and 3A inhibitory properties of Danshen tincture.
Wang X; Yeung JH
Phytomedicine; 2012 Feb; 19(3-4):348-54. PubMed ID: 22056022
[TBL] [Abstract][Full Text] [Related]
5. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.
Spatzenegger M; Horsmans Y; Verbeeck RK
Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Schisandra chinensis (Wuweizi) constituents on the activity of hepatic microsomal CYP450 isozymes in rats detected by using a cocktail probe substrates method].
Wang BL; Hu JP; Sheng L; Li Y
Yao Xue Xue Bao; 2011 Aug; 46(8):922-7. PubMed ID: 22007516
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium ozagrel on the activity of rat CYP2D6.
Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of human CYP1A2 using a targeted antibody.
Adams DA; Edwards RJ; Davies DS; Boobis AR
Biochem Pharmacol; 1997 Jul; 54(1):189-97. PubMed ID: 9296366
[TBL] [Abstract][Full Text] [Related]
9. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
[TBL] [Abstract][Full Text] [Related]
11. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
12. Application of the PKCYP-test in cases of altered CYP1A2 for multiple CYP systems in rat models of disease.
Matsunaga N; Hattori K; Iizasa H; Kizu J; Takanaka A; Nakashima E
Biol Pharm Bull; 2001 Sep; 24(9):1037-43. PubMed ID: 11558565
[TBL] [Abstract][Full Text] [Related]
13. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
14. [Sex-difference on flutamide metabolism in rat liver microsomal cytochrome P450 1A2].
Wang HX; Li D; Xu CJ; Liu X
Yao Xue Xue Bao; 2002 Aug; 37(8):608-10. PubMed ID: 12567773
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.
Lee SH; Slattery JT
Drug Metab Dispos; 1997 Dec; 25(12):1354-8. PubMed ID: 9394024
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Qingkailing injection on rat CYP1A2 and CYP2D6 activity].
Liu Y; Wang J; Bao YY; Yu WJ; Zhu DL
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2044-7. PubMed ID: 18161301
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
19. Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
Fuhr U; Kober S; Zaigler M; Mutschler E; Spahn-Langguth H
Int J Clin Pharmacol Ther; 2005 Jul; 43(7):327-34. PubMed ID: 16035375
[TBL] [Abstract][Full Text] [Related]
20. Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Duan SX; Karsov D; Shader RI
Pharmacology; 1996 Feb; 52(2):125-34. PubMed ID: 8851634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
